In 1980, Reuben Andresen observed that in certain Background: individuals, obesity did not increase mortality, introducing an atypical phenotype called "healthy obese". Other studies reported that 10-15 % of lean individuals presented insulin resistance, hyperglycemia and dyslipidemia. The objective of this study was to evaluate biochemical and clinical characteristics of metabolic phenotypes in Maracaibo city.
Introduction
Obesity is considered an entity with major morbi-mortality in the world since the end of the 20th century 1 . Multiples studies have shown its role as an independent risk factor for various cardiometabolic disorders such as hypertension (HTN), dyslipidemias, Type 2 Diabetes Mellitus (T2DM) and cardiovascular disease (CVD) 2 . For this reason, the actual clinical practice catalogues the typical obese patient as an "unhealthy" patient or a patient with comorbidities.
In spite of this, in 1980, Reuben Andresen discovered that in certain groups of individuals the obesity was not a mortality increasing factor, introducing the subtype "Healthy Obese" 3 . Around 20 years later, Ferranini et al. observed that a group of certain obese nondiabetic non-hypertensive subjects presented low insulin resistance (IR) prevalence, suggesting that this subtype must have a different risk of having T2DM and CVD from the IR obese; also suggesting a different management for them 4 . Furthermore, in 1975, Bernstein et al. observed that 11 normalweight men with type IV or V dyslipidemia presented higher serum glucose levels; and also carried bigger sized adipocytes with respect to their healthy counterparts 5 . Years later, Ruderman et al. introduced the "Metabolically Unhealthy Normal-Weight" phenotype attributed to lean individuals with metabolic alterations associated to obesity 6 .
The importance of these atypical metabolic phenotypes lies in the fact that their diagnosis may be challenging for clinicians delaying their detection. Because of this, in recent years, multiple studies have been dedicated to the research of accurate clinical, biochemical, and genetic elements capable to detect these atypical metabolic states, and their evolution. Likewise, it has been discussed whether the use of certain anthropometric parameters is enough to classify the subjects as healthy or sick from a cardiometabolic perspective.
In this sense, these phenotypes determinants and frequencies have not been deeply researched in Latin-American populations 7 . Despite the wide heterogeneity observed in our region influenced for genetic and environmental factors as well as the similar prevalence of cardiometabolic diseases in Maracaibo city and other localities from the continent. The objective of this study is to characterize, from a clinical-biological point of view, the metabolic phenotypes in the population from Maracaibo city, Venezuela.
Materials and methods

Population selection
The Maracaibo City Metabolic Syndrome Prevalence Study (MMSPS) is a cross-sectional study whose purpose is to detect metabolic syndrome and cardiovascular disease risk factors in the adult population from Maracaibo, the second largest city of Venezuela, with approximately 2,500,000 inhabitants, during the period May 2007 -December 2009. The original study included a total of 2230 individuals of both genders, aged between 18-85 years old, and the study protocol was previously reported 8 . This sub-analysis excluded those individuals with no measurements of serum insulin levels. Patients with past history of diabetes were also excluded because their disease control, evolution and pharmacological treatments would affect the variables in the study.
In order to avoid classifying the subjects according to a priori pre-established definitions, a cluster analysis was carried out that allowed selecting the main variables in the definition of healthy-sick subjects by data mining technique. In this way, these subjects were categorized into six groups, first according to their Body Mass Index (BMI) (normal-weight, overweight and obese) and second, to their healthy/unhealthy definition. This categorization was made using the protocol from two-step cluster analysis published previously 9 . The metabolic variables were chosen as possible metabolic predictors based on their physiological function and biological plausibility. These variables were: mean arterial pressure (MAP), triglycerides (TAG), total cholesterol, HDL-C, HOMA2-IR, HOMA2-βcell, HOMA2-S, fasting blood glucose, non-HDL-C cholesterol, TAG/HDL-C ratio, and high-sensitivity C-Reactive Protein (hs-CRP) levels; waist circumference (WC) was excluded and was assessed as a dependent variable.
The most appropriate predictive variables selected, according predictive strength for each group were: (a) HOMA2-IR and HOMA2-βcell for normal-weight women; (b) HOMA2-IR, HOMA2-βcell and TAG for normal-weight men; (c) HOMA2-IR Amendments from Version 1 1. In the "Abstract" section: all data requested in methodology were added (concisely as it would carry a large number of words). The results were edited in order to improve the understanding regarding the frequency of each phenotype. The conclusion was also edited to facilitate comprehension according to the reviewer's suggestion.
2. The Introduction section was edited and expanded.
3. In the methodology section, population selection was edited, for both, improving its comprehension, and explaining that cluster analysis was conducted to select the healthy and sick subjects. However, we consider that it is important to be maintained for the description of certain methodological details as well as the variables included in the analysis. 4. Regarding physical activity, table 1 was eliminated and physical activity domains were reclassified into 2 categories (Inactive and active) to simplify the analysis and description of the physical activity throughout the work.
5.
In relation to the Framingham-Wilson calibrated equation, the drafting was edited and improved. Asymptomatic events are in reference to myocardial infarction only excluding angina events. Table 2 , we change "Indian-American" for "Native American". 7. A post-hoc analysis of the differences between the quantitative variables of Table 6 (now Table 5 ) was added. The description was detailed on the basis of these findings.
In
8. The section "metabolic phenotypes and coronary risk classification" was edited, highlighting positive result only in obese subjects. Figure 1 . Patient selection diagram. Maracaibo city, Venezuela. During sample selection, subjects with no measurements of serum insulin levels and patients with past history of diabetes were excluded. These subjects were categorized into six groups, first according to their BMI and second to their healthy/unhealthy definition, using two-step cluster analysis. and HOMA2-βcell for overweight women; (d) HOMA2-IR, HOMA2-βcell, and TAG for overweight men; and (e) HOMA2-IR for male and female obese patients. The two-step cluster analysis was conducted with SPSS, the program analyzed the subclusters with the characteristics of each BMI category and categorized the subjects into 6 phenotypes: healthy normal-weight (HNW), metabolically unhealthy normal-weight (MUNW), healthy and metabolically disturbed overweight, metabolically unhealthy obese (MUO), and metabolically healthy obese (MHO). Overweight subjects were excluded from this secondary analysis since they represent a non-conventional group outside the metabolic phenotypes and require separate analysis. The final sample included 1226 subjects ( Figure 1 ).
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Clinical evaluation
Data was collected through completion of a full clinical record carried out by trained personnel, which included interrogation regarding ethnic origin and socioeconomic status by the Graffar scale according to Méndez-Castellano 10 . The assessment of blood pressure was done by applying the auscultatory technique, and HTN classification was made using the criteria proposed in the VII Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure 11 .
For Anthropometric Analysis, an electrical bioelectric scale was used to obtain weight (Tanita, TBF-310 GS Body Composition Analyzer, Tokyo -Japan). Height was measured using a calibrated metric measurement tape, with the subject standing up barefoot. BMI formula (weight/height 2 ) was applied, expressing the results as kg/m 2 . Obesity was classified applying the WHO criteria 12 based on the BMI value. Finally, WC was measured using calibrated measuring tape in accordance to the anatomical landmarks proposed by the USA National Institutes of Health protocol 13 .
Physical activity. Physical activity (PA) was assessed with the International Physical Activity Questionnaire (IPAQ). For statistical analysis, PA was evaluated in 4 domains: occupational, household, transport, and leisure. In each of these domains, subjects were categorized as follows: (a) inactive, MET/week = 0, or (b) active, MET/week > 0.
Biochemical analyses
Fasting levels of glucose, cholesterol, TAG, HDL-C, and hs-CRP were assessed in our clinical laboratory using an automatized computer analyzer (Human Gesellschaft fur Biochemica und Diagnostica mbH). LDL-C and VLDL-C levels were calculated applying the Friedewald formulas 14 . When TAG were over 400 mg/dL measurement was done using lipoprotein electrophoresis and optical densitometry (BioRad GS-800 densitometer, USA). Lipoprotein (a) [Lp(a)] was estimated through the latex turbidimetric method, Human Gesellschaft für Biochemica and Diagnostica, Germany. Likewise, serum hs-CRP levels were quantified employing immunoturbidimetric essays (Human Gesellschaft für Biochemica and Diagnostica MBH). Insulin was determined using an ultrasensitive ELISA method (DRG Instruments GmbH, Germany, International DRG Division, Inc.). For the evaluation of insulin resistance (IR), 2 was the cut-off to define it 15 , the HOMA2-IR model proposed by Levy et al. was utilized 16 determined through the HOMA-Calculator v2.2.2 program. Visceral Adiposity Index (VAI) calculation was performed with the gender-specific equations proposed by Amato et al. 17 . The Metabolic Syndrome (MS) diagnosis was done using the Harmonizing-2009 consensus criteria 18 .
Calibration of the Framingham-Wilson equation and coronary risk categorization for the population of Maracaibo city
For proper equation calibration, the constants in the formula regarding major cumulative coronary events (lethal and non-lethal, symptomatic and no symptomatic myocardial infarction, angina) were substituted with the local statistics obtained from the Vital Statistics Yearbook of the State of Zulia from 2008, where the morbidity and mortality for cardiovascular diseases is registered, the calibration process has been detailed previously 19 . The coronary risk was classified in 2 categories: <5% in 10 years, and ≥5% in 10 years.
Statistical analysis
Normal distribution of continuous variables was assessed using Geary's test; for normally distributed variables, the results were expressed as arithmetic mean ± SD (standard deviation). Variables without normal distribution were logarithmically transformed, and normal distribution subsequently corroborated. When normalization could not be achieved, these variables were expressed as medians (25 th percentile-75 th percentile). Student's -test/One-way ANOVA or Mann-Whitney/Kruskal Wallis's tests were applied to evaluate differences between means or medians, respectively. Qualitative variables were expressed as absolute and relative frequencies, assessed through the χ 2 test and the Z test for Proportions. A logistic regression model was constructed with coronary risk as dependent variable and independent variables: gender, age groups, ethnicity, socioeconomic status, smoking habit, physical activity in leisure time, elevated TAG, and metabolic phenotypes.
Database construction and statistical analysis were done using the Statistical Package for the Social Sciences (SPSS) v22 for Windows (IBM Inc., Chicago, IL), results were considered statistically significant when p<0.05.
Results
Population general characteristics
A total of 1226 individuals were studied, 55.1% (n=676) corresponded to females and 44.9% (n=550) to males. The mean age (years) of the general population was 37.94±14.99. Subjects distribution according to their metabolic phenotype is shown in Figure 2 where the 5.2% (n=64) of the individuals were classified as MUNW, and 17.4% (n=213) as MHO, representing 34.13% from the total of obese subjects, while sociodemographic and metabolic characteristics from the studied simple are shown in Table 1 .
Metabolic phenotypes and sociodemographic characteristics
In the evaluation of the epidemiologic behavior of the metabolic phenotypes according to sex, we found that HNW and MUO individuals were predominately females (62.5%, n=336; 51.3%, n=211 respectively), while the atypical phenotypes were predominately males (MUNW: 56.3%, n=36; MHO: 52.6%, n=112. χ 2 =22.53, p<0.001). Likewise, a statistically significant association was found between age groups and metabolic phenotypes (χ 2 = 211.91, p<0.001), observing a predominance in the < 30 years age group in the normal-weight phenotype (HNW: 56.1%, n=302; MUNW: 57.8%, n=37), whereas the 30-49 age group was predominately obese phenotypes (MHO: 47.9%, n=102; MUO: 50.1%, n=106). There was no statistically significant association between metabolic phenotypes, ethnic groups (χ 2 = 20.96, p=0.05) and socioeconomic status (χ 2 = 14.56, p=0.27) ( Table 2) .
Metabolic phenotypes and psychobiologic habits
Initially, in relation to the smoking habit, the non-smokers were the most frequent group (χ 2 =30.91; p<0.001), despite the fact MUNW phenotype consisted of the highest percentage of 2%, n=83 ). On the other side, in the evaluation of the metabolic phenotypes according to PA there was a statistically significant association in the transport-related physical activity (χ 2 =26.93; p<0.001) and leisure activities (χ 2 =19.75; p<0.001) (Table 3) .
Phenotypes and endocrine-metabolic alterations
Distribution of subjects according to phenotypes and endocrinemetabolic alterations are shown in Finally, a significant association was found between the metabolic phenotypes with low HDL-C (χ 2 =44.08; p<0.0001) and HTN (χ 2 = 182.22, p<0.0001).
Metabolic phenotypes and biologic-anthropometric variables
Biochemical and clinical characteristics according to metabolic phenotypes are shown in Table 5 . An increasing tendency of their variable levels was observed, except on HOMA2-IR, HOMA2-βcell, HOMA2-S, insulin and glucose levels whose values were higher in sick subjects; while individuals with obesity had lower levels of HDL-C.
Metabolic phenotypes and coronary risk classification
An association between metabolically unhealthy phenotypes and a higher risk of a coronary event was found in univariate analysis. However, results were statistically significant only for obese individuals when multivariate adjustment was applied (MHO: OR=1.85 CI95%: 1.11-3.09; p=0.02 and MUO: OR=2.09 CI95%: 1.34-3.28; p<0.01) ( 
Discussion
Obesity is a prioritized area for the world health systems because of its increasing prevalence, incidence, and associated costs in the last decade 20 . This disease has been defined classically as "excessive presence of adipose tissue that is injurious for health" and given its association to other chronic-degenerative diseases 3,21 has been stereotyped as "more adiposity, more risk". All the classic methods employed for obesity diagnosis, even central and global, are indirect measurements. For different populations they do not allow to determine the adipose tissue functioning from individuals, even though they have high sensitivity, specificity, and predictive values. Based on this, multiple epidemiologic studies have detected a considerable percentage of individuals who did not enter in the classic "HNW" and "MUO" phenotypes, showing the existence of atypical metabolic phenotypes called "MUNW" and "MHO" 3 . The defining criteria of these metabolic states differ significantly between studies and are defined under highly subjectivity levels, nonetheless insulin sensitivity and lipid profile are often used to define healthy and unhealthy phenotypes 22-24 .
Giving this criteria and methods discrepancy, such as the psychobiologic, sociodemographic, and genetic patterns according to latitudes, the phenotype frequency presents high variability 25 . This could bias the study by selecting predetermined variables and cut-off points to consider an individual as healthy or unhealthy. In this sense, data mining techniques were proposed to avoid potential bias. The program would group subjects according to spontaneous tendencies and biologic behavior of related variables. The atypical metabolic phenotypes, as MUNW and MHO, tend to be observed in females with more frequency 32,34 . However, the present study reported these phenotypes were more frequent in males. Significant difference between sexes was found in the MUNW group, similar to the study by Hinnouko et al. 35 . Smoking habit, age, and physical activity values, were discovered as influencing factors in these findings.
In the same manner, multiple studies have reported that healthy phenotype prevalence decreases with age 27,29 , but in our population an increase was observed in the frequency of MHO individuals older than 30 years old. Yoo et al. 36 did not report differences in this phenotype prevalence between subjects older and younger than 35 years. Regarding the MUNW phenotype in the Maracaibo population, a higher frequency was found in subjects younger than 30 years. A considerable part of epidemiologic studies that evaluate this association possessed samples conformed by subjects older than 35 years. This may limit the establishment of a tendency in frequency of healthy phenotypes according to age. Similarly, factors such as ethnicity from African descendants 37 and socioeconomical status 38 have been related to the presence of atypical phenotypes, but no relationship was found between these variables in Maracaibo population.
One of the greatest enigmas formulated in relation to the atypical metabolic phenotypes, is focused on its conditioning factors. Psychobiologic habits have been considered key elements in comprehension of its biology and behavior related to time. Diniz et al. 39 found a significant association between healthy metabolic phenotypes with absence of smoking habit, also with increased PA levels, such as the present study. Ortega et al. 40 reported that MHO subjects present with better cardiorespiratory fitness profiles than their unhealthy counterpart, and by adjusting for this Regarding to cardiometabolic profiles, our study showed evidence of significantly higher HOMA2-βcell values in all of the unhealthy phenotypes, described previously by the NHANES study 41 and by Madeira et al. 42 . Also higher HOMA2-IR and a lower HOMA2-S demonstrate again the importance to define metabolic states in lean and obese individuals. They could also elevate the risk of developing T2DM and CVD in the unhealthy phenotypes, given their hyper functioning pancreatic beta cell and hyperinsulinemia 43 .
MHO subjects present with lower HOMA2-IR and higher TAG, LDL-C, PAS, PAD, and hs-CRP levels. In contrast to lean subjects, MHO has higher VAI. The latter constitutes an initial obesity state, without a significant risk of T2DM and CVD in the short term (7-11 years) 44 , but there is in the long term (>16-30 years) 45 . The natural history of the MHO is variable, only 16% of MHO individuals stay on that status without alteration for the following 7-8 years 46 . Those who progress to an unhealthy state present a higher risk of high blood pressure, low-grade inflammation, bad metabolic control and high TAG 30 . In spite of the metabolic "benign" state of the MHO adipose tissue, non-metabolic complications of obesity, do not exclude these subjects from getting T2DM, CVD, and chronic diseases associated with obesity in the future 34, 35 .
Healthy obese individuals must be classified in categories with higher risk of a coronary event compared to lean subjects. This is consistent with previous reports related to metabolic phenotypes and CVD, suggesting that healthy obese subjects have a higher risk profile in comparison to those with lower BMI 36 ; as well as an increased risk for CVD 47 and metabolic disorders such as fatty liver and low-grade inflammation 7 . Given the above, a profound evaluation of these patients is recommended. This includes not only obese subjects but also those who are overweight, which can go unnoticed in a routine consultation and CVD could be subclinical; as it has been demonstrated by Khan et al. in 475 women from the SWAN study 48 .
Finally, despite the fact that our report presents a novel method to classify healthy and unhealthy subjects, it is important to mention the difficulty to follow-up these individuals. The latter would show the atypical phenotype stability related to time, as well as the incidence of T2DM and CVD. This was the main limitation of our study. In addition our study lacks nutritional data. For this reason, a through and constant evaluation of subjects with atypical metabolic phenotypes is recommended, given their demonstrated unsteadiness in time, and associated non metabolic comorbidities observed especially in the MHO individuals. 
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